Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies. - Wikidata - awgldk - TriplyDB

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

http://www.wikidata.org/entity/Q37530222

about

Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.The multiple facets of FcRn in immunity.Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients.FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients

P2860

Q34438000-EB867D51-5C92-42CB-B1C3-7D3AA649C524 Q35670904-0D59385E-4C5F-474F-93D2-D331D06FA6E4 Q37685527-DF95B4DE-4F3C-48B8-883D-533E3A1BA035 Q38615385-B3A047BC-EA2B-46AC-B760-0F00B094AF5E Q40533983-40465033-9B60-4997-B7C3-907219A05A29 Q41139422-B3982B30-4BA0-4ACE-A4B5-454214D94339 Q41940445-15D64239-8A42-483D-A8C8-525288D2F089

P2860

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

http://www.wikidata.org/entity/Q37530222

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

@en

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

@nl

type

label

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

@en

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

@nl

prefLabel

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

@en

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

@nl

P1433

Q37530222-2E53665E-4096-4DFC-9ED4-71779DB314B0

P1476

Q37530222-6C40C9DA-DEB5-43DB-B832-84E98C0C8ABC

P2093

Q37530222-0B91E11C-1783-4103-A7BE-6FFAFF657D45

Q37530222-7A042991-2D6D-4297-BC44-4AC63B292121

Q37530222-85A99869-8356-46F7-9D6E-CA46475DA1E6

Q37530222-906D4E8C-9C1A-4B6A-879F-1E5F7632BE08

Q37530222-95CB4FD8-C09D-4A12-8B98-BEEED5BB2ADC

Q37530222-976A43C6-AF9C-4811-8A68-74982F18735E

Q37530222-A5210164-B302-4817-9A14-8BAB4E83F072

Q37530222-C4EC6230-03A4-498D-B7E5-5E8C8E558898

Q37530222-CA301128-A045-402A-AD74-6D295EAA0F29

Q37530222-CB7B6938-84F1-45B7-B43A-FF28EBCC5BAA

P2860

Q37530222-2042B32B-C067-451C-B73C-8FF8ACCC61CF

Q37530222-2CA95303-1026-45EF-A8C3-042FF5784A66

Q37530222-34D82D60-3A3C-4DD3-BB63-B19553E88D8C

Q37530222-3547DB77-376A-4F15-B590-353CFA147629

Q37530222-636EB252-5F46-4218-B9A7-971BFDEE79B8

Q37530222-74604013-7D0B-4C6B-989F-7CC61EEACA5F

Q37530222-74F70E02-09BB-44ED-BF06-AB4F9B081D9F

Q37530222-770C6538-A4F3-444F-80B4-20D66DFFCE6B

Q37530222-7D60C8AE-1FCD-4A94-B0BC-8CB27BEEC446

Q37530222-7D8C336D-3D53-4F3C-90E0-2A9392D11939

P304

Q37530222-F80FC945-AA5D-4D79-A0B6-6A8417F2066D

P31

Q37530222-734DC999-3A2F-4CD7-9EFD-995204C50A73

P356

Q37530222-E6C835A7-1DD2-4480-965E-65DDEDBD8910

P433

Q37530222-2F567EE6-3BDD-4A08-AAC8-2A84DE88780C

P478

Q37530222-ED582B2B-4172-42B2-9C61-3B85D5A7884A

P577

Q37530222-AEE05F0C-4A0B-43CE-9727-A9E8808EE432

P5875

Q37530222-01C3F1E9-FCD7-4FC1-95FD-A5289E31E6A3

P698

Q37530222-5A7D4BDF-49EC-4B3D-96C5-E519CD6B3D6E

P921

Q37530222-725D570D-D7AC-4F70-AF37-02039462BA89

P932

Q37530222-89E73670-52C4-4A67-BC10-D1F0EE8CE2EC

P356

P1433

Monoclonal Antibodies

P1476

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

@en

P2093

Christophe Arnoult

http://www.w3.org/2001/XMLSchema#string

Christophe Passot

http://www.w3.org/2001/XMLSchema#string

Erick Gamelin

http://www.w3.org/2001/XMLSchema#string

Gilles Paintaud

http://www.w3.org/2001/XMLSchema#string

Hervé Watier

http://www.w3.org/2001/XMLSchema#string

Marc Ohresser

http://www.w3.org/2001/XMLSchema#string

Michèle Boisdron-Celle

http://www.w3.org/2001/XMLSchema#string

Nadine Baroukh

http://www.w3.org/2001/XMLSchema#string

Nicolas Azzopardi

http://www.w3.org/2001/XMLSchema#string

Sylvaine Renault

http://www.w3.org/2001/XMLSchema#string

P2860

Structural variation in the human genome

The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan

Large-scale copy number polymorphism in the human genome

Receptor-mediated transport of IgG

Cloning and analysis of the gene encoding the human neonatal Fc receptor.

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.

Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies.

Structure and transcription of a human gene for H1 RNA, the RNA component of human RNase P.

Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.

Copy number variants in pharmacogenetic genes.

P304

614-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/MABS.24815

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237096353

http://www.w3.org/2001/XMLSchema#string

P698

23751752

http://www.w3.org/2001/XMLSchema#string

P921

P932

3906315

http://www.w3.org/2001/XMLSchema#string